デフォルト表紙
市場調査レポート
商品コード
1439679

腹圧性尿失禁デバイスの世界市場:洞察、競合情勢、市場予測:2030年

Stress Urinary Incontinence Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
腹圧性尿失禁デバイスの世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の腹圧性尿失禁デバイスの市場規模は、2023年に7億5,700万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に6.91%のCAGRで拡大し、2030年には11億3,032万米ドルに達すると予測されています。腹圧性尿失禁デバイス市場は、女性の尿失禁症例の有病率の上昇、腹圧性尿失禁になりやすい高齢化人口の急増、骨盤底の弱体化、革新的なデバイスの開発、妊娠、糖尿病、更年期を含む条件によって引き起こされる身体的問題がこれらのデバイスの需要を押し上げ、それによって2024年から2030年までの予測期間中に腹圧性尿失禁デバイス市場の成長に貢献するため、プラスの成長を示しています。

腹圧性尿失禁デバイス市場は、様々な理由により製品需要が増加しています。この背景には、高齢者人口の間で世界的に腹圧性尿失禁の症例が増加していることがあります。

WHOの高齢者総合ケア(ICOPE)ガイドラインによると、高齢者の尿失禁の一般的なタイプは腹圧性尿失禁(SUI)です。

Urology Care Foundation 2022によると、全世界で約3人に1人の女性が人生のある時点でSUIに苦しんでいます。尿失禁は年齢とともに増加します。SUIの女性の半数以上は過活動膀胱でもあります。さらに、60歳の女性の約3分の1(3人に1人)、65歳の女性の約半数(2人に1人)が、時々尿を漏らしていると感じています。

当レポートでは、世界の腹圧性尿失禁デバイス市場について調査し、市場の概要とともに、製品別、タイプ別、患者タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 腹圧性尿失禁デバイス市場レポートのイントロダクション

第2章 腹圧性尿失禁デバイス市場のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 腹圧性尿失禁デバイス市場の主な要因分析

  • 腹圧性尿失禁デバイス市場の促進要因
  • 腹圧性尿失禁デバイス市場の抑制要因と課題
  • 腹圧性尿失禁デバイス市場の機会

第5章 腹圧性尿失禁デバイス市場におけるポーターのファイブフォース分析

第6章 腹圧性尿失禁デバイス市場に対するCOVID-19の影響分析

第7章 腹圧性尿失禁デバイスの市場概要

  • 製品別
  • タイプ別
  • 患者タイプ別
  • エンドユーザー別
  • 地域別

第8章 腹圧性尿失禁デバイス市場の世界企業シェア分析-主要3~5社

第9章 腹圧性尿失禁デバイス市場の企業と製品プロファイル

  • Boston Scientific Corporation
  • AscentX Medical Inc.
  • Coloplast Corporation
  • Becton, Dickinson and Company
  • ConvaTec Group PLC
  • Ethicon US, LLC (Johnson & Johnson)
  • Cook Medical Inc.
  • Teleflex Incorporated
  • Caldera Medical Inc.
  • Prosurg, Inc.
  • Laborie
  • InControl Medical
  • Cousin Surgery
  • Hollister Incorporated
  • ZSI Surgical Implants
  • Atlantic Therapeutics
  • Flexicare (Group) Limited
  • A.M.I. GmbH
  • Axonics, Inc.
  • Betatech Medical

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Stress Urinary Incontinence Devices Market in Global (2021-2030)
  • Table 4: Stress Urinary Incontinence Devices Market in Global by Product (2021-2030)
  • Table 5: Stress Urinary Incontinence Devices Market in Global by Type (2021-2030)
  • Table 6: Stress Urinary Incontinence Devices Market in Global by Patient Type (2021-2030)
  • Table 7: Stress Urinary Incontinence Devices Market in Global by End User (2021-2030)
  • Table 8: Stress Urinary Incontinence Devices Market in Global by Geography (2021-2030)
  • Table 9: Stress Urinary Incontinence Devices Market in North America (2021-2030)
  • Table 10: Stress Urinary Incontinence Devices Market in North America by Country (2021-2030)
  • Table 11: Stress Urinary Incontinence Devices Market in the US (2021-2030)
  • Table 12: Stress Urinary Incontinence Devices Market in Canada (2021-2030)
  • Table 13: Stress Urinary Incontinence Devices Market in Mexico (2021-2030)
  • Table 14: Stress Urinary Incontinence Devices Market in Europe (2021-2030)
  • Table 15: Stress Urinary Incontinence Devices Market in Europe by Country (2021-2030)
  • Table 16: Stress Urinary Incontinence Devices Market in France (2021-2030)
  • Table 17: Stress Urinary Incontinence Devices Market in Germany (2021-2030)
  • Table 18: Stress Urinary Incontinence Devices Market in the United Kingdom (2021-2030)
  • Table 19: Stress Urinary Incontinence Devices Market in Italy (2021-2030)
  • Table 20: Stress Urinary Incontinence Devices Market in Spain (2021-2030)
  • Table 21: Stress Urinary Incontinence Devices Market in Russia (2021-2030)
  • Table 22: Stress Urinary Incontinence Devices Market in Rest of Europe (2021-2030)
  • Table 23: Stress Urinary Incontinence Devices Market in APAC (2021-2030)
  • Table 24: Stress Urinary Incontinence Devices Market in APAC by Country (2021-2030)
  • Table 25: Stress Urinary Incontinence Devices Market in China (2021-2030)
  • Table 26: Stress Urinary Incontinence Devices Market in Japan (2021-2030)
  • Table 27: Stress Urinary Incontinence Devices Market in India (2021-2030)
  • Table 28: Stress Urinary Incontinence Devices Market in Australia (2021-2030)
  • Table 29: Stress Urinary Incontinence Devices Market in South Korea (2021-2030)
  • Table 30: Stress Urinary Incontinence Devices Market in Rest of APAC (2021-2030)
  • Table 31: Stress Urinary Incontinence Devices Market in Rest of World (2021-2030)
  • Table 32: Stress Urinary Incontinence Devices Market in RoW by Region (2021-2030)
  • Table 33: Stress Urinary Incontinence Devices Market in Middle East (2021-2030)
  • Table 34: Stress Urinary Incontinence Devices Market in Africa (2021-2030)
  • Table 35: Stress Urinary Incontinence Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Stress Urinary Incontinence Devices Market in Global (2021-2030)
  • Figure 4: Stress Urinary Incontinence Devices Market in Global by Product (2021-2030)
  • Figure 5: Stress Urinary Incontinence Devices Market in Global by Type (2021-2030)
  • Figure 6: Stress Urinary Incontinence Devices Market in Global by Patient Type (2021-2030)
  • Figure 7: Stress Urinary Incontinence Devices Market in Global by End User (2021-2030)
  • Figure 8: Stress Urinary Incontinence Devices Market in Global by Geography (2021-2030)
  • Figure 9: Stress Urinary Incontinence Devices Market in North America (2021-2030)
  • Figure 10: Stress Urinary Incontinence Devices Market in North America by Country (2021-2030)
  • Figure 11: Stress Urinary Incontinence Devices Market in the US (2021-2030)
  • Figure 12: Stress Urinary Incontinence Devices Market in Canada (2021-2030)
  • Figure 13: Stress Urinary Incontinence Devices Market in Mexico (2021-2030)
  • Figure 14: Stress Urinary Incontinence Devices Market in Europe (2021-2030)
  • Figure 15: Stress Urinary Incontinence Devices Market in Europe by Country (2021-2030)
  • Figure 16: Stress Urinary Incontinence Devices Market in France (2021-2030)
  • Figure 17: Stress Urinary Incontinence Devices Market in Germany (2021-2030)
  • Figure 18: Stress Urinary Incontinence Devices Market in the United Kingdom (2021-2030)
  • Figure 19: Stress Urinary Incontinence Devices Market in Italy (2021-2030)
  • Figure 20: Stress Urinary Incontinence Devices Market in Spain (2021-2030)
  • Figure 21: Stress Urinary Incontinence Devices Market in Russia (2021-2030)
  • Figure 22: Stress Urinary Incontinence Devices Market in Rest of Europe (2021-2030)
  • Figure 23: Stress Urinary Incontinence Devices Market in APAC (2021-2030)
  • Figure 24: Stress Urinary Incontinence Devices Market in APAC by Country (2021-2030)
  • Figure 25: Stress Urinary Incontinence Devices Market in China (2021-2030)
  • Figure 26: Stress Urinary Incontinence Devices Market in Japan (2021-2030)
  • Figure 27: Stress Urinary Incontinence Devices Market in India (2021-2030)
  • Figure 28: Stress Urinary Incontinence Devices Market in Australia (2021-2030)
  • Figure 29: Stress Urinary Incontinence Devices Market in South Korea (2021-2030)
  • Figure 30: Stress Urinary Incontinence Devices Market in Rest of APAC (2021-2030)
  • Figure 31: Stress Urinary Incontinence Devices Market in Rest of World (2021-2030)
  • Figure 32: Stress Urinary Incontinence Devices Market in RoW by Region (2021-2030)
  • Figure 33: Stress Urinary Incontinence Devices Market in Middle East (2021-2030)
  • Figure 34: Stress Urinary Incontinence Devices Market in Africa (2021-2030)
  • Figure 35: Stress Urinary Incontinence Devices Market in South America (2021-2030)
  • Figure 36: Market Drivers
  • Figure 37: Market Barriers
  • Figure 38: Marker Opportunities
  • Figure 39: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0519

Stress Urinary Incontinence Devices Market By Product (Vaginal Pessaries, Sling Systems, Artificial Urinary Sphincters, Urethral Bulking Agent, Others), By Type (External Devices, Internal Devices), By Patient Type (Male, Female), By End-User (Hospitals, Ambulatory Surgery Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of urinary incontinence cases among women and rapid technological developmental activities

Global Stress Urinary Incontinence Devices Market was valued at USD 757 Million in 2023, growing at a CAGR of 6.91% during the forecast period from 2024 to 2030 to reach USD 1130.32 Million by 2030. The Stress Urinary Incontinence Devices market is witnessing positive growth owing to the rising prevalence of urinary incontinence cases among women, a surge in the aging population prone to stress urinary incontinence and weakening of pelvic floor, development of innovative devices, physical problems caused due to conditions including pregnancy, diabetes, menopause, pushes the demand of these devices, thereby contributing to the growth of the Stress Urinary Incontinence Devices market during the forecast period from 2024-2030.

Stress Urinary Incontinence Devices Market Dynamics:

The Stress Urinary Incontinence Devices market is witnessing a growth in product demand owing to various reasons. This is due to the rising cases of stress urinary incontinence worldwide among the geriatric population.

As per the Integrated care for older people (ICOPE) Guidelines by WHO, the common types of urinary incontinence in older people are stress incontinence.

As per Urology Care Foundation 2022, about 1 in 3 women suffer from SUI globally at some point in their lives. Urinary incontinence increases with age. Over half of women with SUI also have an Overactive Bladder. Moreover, about one-third (1 out of 3) of women aged 60 and about half (1 out of 2) of women aged 65 find that they sometimes leak urine.

According to the National Association for Incontinence statistics, one in four women globally over the age of 18 experience episodes of leaking urine involuntarily.

Moreover, urinary incontinence is a very common and debilitating problem affecting about 50% of women globally at some point in their lives. As per the European Association of Urology 2018, Urinary Incontinence affects 200 million people worldwide.

According to the International Association of Urinary Incontinence (ICS) 2019, it is estimated that ten to 20% of all women and 77% of women living in nursing homes have stress urinary incontinence.

Considering the high global prevalence of Stress UI, the majority of the research concerning the domain is underway, resulting in the majority of products being approved. Hence, the significant research activities taking place will eventually boost the market.

Therefore, the increasing prevalence of stress urinary incontinence among the geriatric and female population will contribute to the Stress Urinary Incontinence Devices market.

However, postoperative complications and less awareness among the patient population regarding stress incontinence may be certain limiting factors of the Stress Urinary Incontinence Devices market growth.

The ongoing Coronavirus disease 2019 pandemic has highly impacted the market for Urinary Incontinence Devices as hospital admissions for urinary incontinence diseases were not a priority in comparison to the patients suffering from Coronavirus. However, with the population getting vaccinated at a high rate, the market for Urinary Incontinence Devices is expected to grow in the study period.

Stress Urinary Incontinence Devices Market Segment Analysis:

Stress Urinary Incontinence Devices Market By Product (Vaginal Pessaries, Sling Systems, Artificial Urinary Sphincters, Urethral Bulking Agent, Others), By Type (External Devices, Internal Devices), By Patient Type (Male, Female), By End-User (Hospitals, Ambulatory Surgery Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product segment of the Stress Urinary Incontinence Devices market, Sling Systems are estimated to hold a higher share in the Stress Urinary Incontinence Devices market during the forecast period (2024-2030). This can be attributed to the specific features associated with these devices.

The demand for Sling Systems is expected to witness an increased demand during the forecasted period. This is due to the rising cases of stress urinary incontinences worldwide and growing patient adoption for these devices due to quick relief.

Two main types of Sling Systems are used to treat Stress Urinary Incontinence (SUI), which are Midurethral sling, and Traditional sling. These are made up of different materials like ligament, tissue, tendons taken from the patient or they can also be manufactured from synthetic sources like plastic.

Sling Systems are more advanced devices and have replaced all the conventional devices available in the market.

Furthermore, these sling operations have been the most extensively researched surgical treatment for stress urinary incontinence (SUI) in women and have a good safety profile.

Therefore, all these factors are responsible for the segment growth, which will eventually boost the expansion of the Global Stress Urinary Incontinence Market.

North America is expected to dominate the overall Stress Urinary Incontinence Devices Market:

Among all the regions, North America is expected to account for the largest share in the Global Stress Urinary Incontinence Devices market. This domination is owing to the growing prevalence of stress urinary incontinence and surge in the aging population prone to urological conditions like weakening of pelvic floor, and improved product launches are the key factor contributing to the North America Stress Urinary Incontinence Devices Market.

According to the National Association for Continence 2019, up to 40 million women in America have experienced bladder leakage issues at some point in their lives. A study of the year 2019 shows almost half of the new mothers experience incontinence following a normal delivery and about one in six following cesarean section.

As per Urology Care Foundation 2022, a quarter to a third of women in the US suffer from stress urinary incontinence.

Thus, the burgeoning cases of the diseases will contribute to the growth of the Stress Urinary Incontinence Devices Market in the region as the demand will increase.

Additionally, the presence of key market players such as Coloplast Corporation, Becton, Dickinson and Company, Boston Scientific, among others, and their strategic business development activities in the region is also a fuelling factor of the Stress Urinary Incontinence Devices in the region.

Moreover, the rising research and development activities are also boosting the growth of the Stress Urinary Incontinence Devices market. For instance, in March 2022, the National Association for Continence (NAFC), highlighted a new study that offers hope for the 78 million women who experience urinary incontinence (UI). On March 10, the official journal of the American College of Obstetricians and Gynecologists (ACOG), Obstetrics & Gynecology ("the green journal") published a rigorous study showing that women with UI who performed pelvic floor muscle training (PFMT) using leva achieved significant improvement in their UI symptoms and fewer leaks.

Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Stress Urinary Incontinence Devices market during the forecast period. Thus, all the above-mentioned factors are anticipated to propel the market for Stress Urinary Incontinence Devices in the United States region.

Stress Urinary Incontinence Devices Market Key Players:

Some of the key market players operating in the Stress Urinary Incontinence Devices market include Boston Scientific Corporation, AscentX Medical Inc., Coloplast Corporation, Becton, Dickinson and Company, ConvaTec Group PLC, Ethicon US, LLC (Johnson & Johnson), Cook Medical Inc., Teleflex Incorporated, Caldera Medical Inc., Prosurg, Inc., Laborie, InControl Medical, Cousin Surgery, Hollister Incorporated, ZSI Surgical Implants, Atlantic Therapeutics, Flexicare (Group) Limited, A.M.I. GmbH, Axonics, Inc., Betatech Medical, and others.

Recent Developmental Activities in the Stress Urinary Incontinence Devices Market:

In March 2022, Pelvic floor muscle training using a motion-based digital intravaginal device significantly improved symptoms for women with stress urinary incontinence (SUI) compared with a home training program, a virtually conducted randomized controlled trial showed.

Key Takeaways from the Stress Urinary Incontinence Devices Market Report Study

  • Market size analysis for current Stress Urinary Incontinence Devices market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Stress Urinary Incontinence Devices market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global Stress Urinary Incontinence Devices market.
  • Various opportunities available for the other competitor in the Stress Urinary Incontinence Devices market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current Stress Urinary Incontinence Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Stress Urinary Incontinence Devices market growth in the coming future?

Target Audience who can be benefited from this Stress Urinary Incontinence Devices Market Report Study

  • Stress Urinary Incontinence Devices products providers
  • Research organizations and consulting companies
  • Stress Urinary Incontinence Devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Stress Urinary Incontinence Devices
  • Various End-users who want to know more about the Stress Urinary Incontinence Devices market and latest technological developments in the Stress Urinary Incontinence Devices market.

Frequently Asked Questions for the Stress Urinary Incontinence Devices Market:

1. What are Stress Urinary Incontinence Devices?

According to WHO, stress urinary incontinence (SUI) is a leakage of urine during moments of physical activity that increases abdominal pressure, such as coughing, sneezing, laughing, or exercising. SUI is the most common type of urinary incontinence in women.

2. What is the market for Global Stress Urinary Incontinence Devices?

Global Stress Urinary Incontinence Devices Market was valued at USD 757 Million in 2023, growing at a CAGR of 6.91% during the forecast period from 2024 to 2030 to reach USD 1130.32 Million by 2030.

3. What are the drivers for the Global Stress Urinary Incontinence Devices Market?

The Stress Urinary Incontinence Devices market is witnessing a positive market growth owing to the rising prevalence of urinary incontinence cases among women, a surge in the aging population prone to stress urinary incontinence and weakening of pelvic floor, development of innovative devices, physical problems caused due to conditions including pregnancy, diabetes, menopause, pushes the demand of these devices, thereby contributing to the growth of the Stress Urinary Incontinence Devices market during the forecast period from 2024-2030

4. Who are the key players operating in the Global Stress Urinary Incontinence Devices Market?

Some of the key market players operating in the Stress Urinary Incontinence Devices market include Boston Scientific Corporation, AscentX Medical Inc., Coloplast Corporation, Becton, Dickinson and Company, ConvaTec Group PLC, Ethicon US, LLC (Johnson & Johnson), Cook Medical Inc., Teleflex Incorporated, Caldera Medical Inc., Prosurg, Inc., Laborie, InControl Medical, Cousin Surgery, Hollister Incorporated, ZSI Surgical Implants, Atlantic Therapeutics, Flexicare (Group) Limited, A.M.I. GmbH, Axonics, Inc., Betatech Medical, and others.

5. Which region has the highest share in Stress Urinary Incontinence Devices Market?

North America is expected to hold the highest share in the revenue in the Stress Urinary Incontinence Devices market during the forecast period. This domination is owing to the growing prevalence of stress urinary incontinence and surge in the aging population prone to urological conditions like weakening of pelvic floor, and improved product launches are expected to aid in the growth of the North America Stress Urinary Incontinence Devices Market.

Table of Contents

1.Stress Urinary Incontinence Devices Market Report Introduction

2.Stress Urinary Incontinence Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Stress Urinary Incontinence Devices Market Key Factors Analysis

  • 4.1. Stress Urinary Incontinence Devices Market Drivers
    • 4.1.1. The Rising Prevalence of Urinary Incontinence Cases Among Women
    • 4.1.2. A Surge in the Aging Population Prone to Stress Urinary Incontinence and Weakening of Pelvic Floor
    • 4.1.3. Development of Innovative Devices
    • 4.1.4. Physical Problems Caused Due To Conditions Including Pregnancy, Diabetes, Menopause
  • 4.2. Stress Urinary Incontinence Devices Market Restraints and Challenges
    • 4.2.1. Post-Operative Complications
    • 4.2.2. Less Awareness among the Patient Population Regarding Incontinence
  • 4.3. Stress Urinary Incontinence Devices Market Opportunities
    • 4.3.1. Growing Preference For Devices That Can Be Used in Home Settings
    • 4.3.2. Increasing Demand For Minimally-Invasive Surgery Techniques Due To Patient Preference

5. Stress Urinary Incontinence Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Stress Urinary Incontinence Devices Market

7. Stress Urinary Incontinence Devices Market Layout

  • 7.1. By Product
    • 7.1.1. Vaginal Pessaries
    • 7.1.2. Sling Systems
    • 7.1.3. Artificial Urinary Sphincters
    • 7.1.4. Urethral Bulking Agent
    • 7.1.5. Others
  • 7.2. By Type
    • 7.2.1. External Devices
    • 7.2.2. Internal Devices
  • 7.3. By Patient Type
    • 7.3.1. Male
    • 7.3.2. Female
  • 7.4. By End User
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgery Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. North America Stress Urinary Incontinence Devices Market, by Country
      • 7.5.1.1.1. United States
      • 7.5.1.1.2. Canada
      • 7.5.1.1.3. Mexico
    • 7.5.2. Europe
      • 7.5.2.1. Europe Stress Urinary Incontinence Devices Market, by Country
      • 7.5.2.1.1. France
      • 7.5.2.1.2. Germany
      • 7.5.2.1.3. United Kingdom
      • 7.5.2.1.4. Italy
      • 7.5.2.1.5. Spain
      • 7.5.2.1.6. Russia
      • 7.5.2.1.7. Rest of Europe
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. Asia-Pacific Stress Urinary Incontinence Devices Market, by Country
      • 7.5.3.1.1. China
      • 7.5.3.1.2. Japan
      • 7.5.3.1.3. India
      • 7.5.3.1.4. Australia
      • 7.5.3.1.5. South Korea
      • 7.5.3.1.6. Rest of Asia Pacific
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. RoW Stress Urinary Incontinence Devices Market, by Country
      • 7.5.4.1.1. Middle East
      • 7.5.4.1.2. Africa
      • 7.5.4.1.3. South America

8. Stress Urinary Incontinence Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Stress Urinary Incontinence Devices Market Company and Product Profiles

  • 9.1. Boston Scientific Corporation
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. AscentX Medical Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Coloplast Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Becton, Dickinson and Company
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. ConvaTec Group PLC
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Ethicon US, LLC (Johnson & Johnson)
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Cook Medical Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Teleflex Incorporated
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Caldera Medical Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Prosurg, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Laborie
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. InControl Medical
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Cousin Surgery
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Hollister Incorporated
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. ZSI Surgical Implants
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Atlantic Therapeutics
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Flexicare (Group) Limited
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. A.M.I. GmbH
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Axonics, Inc.
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Betatech Medical
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us